Efficacy of night-time compression for breast cancer related lymphedema LYNC: protocol for a multi-centre, randomized controlled efficacy trialReport as inadecuate

Efficacy of night-time compression for breast cancer related lymphedema LYNC: protocol for a multi-centre, randomized controlled efficacy trial - Download this document for free, or read online. Document in PDF available to download.

BMC Cancer

, 16:601

Surgical oncology, cancer imaging, and interventional therapeutics


BackgroundLymphedema is a prevalent long-term effect of breast cancer treatment that is associated with reduced quality of life. More recent observational data suggest that the addition of night-time compression to day-time use of a compression garment results in better long-term control of arm lymphedema. The primary objectives of the randomized controlled phase of the trial are to determine the efficacy of night-time compression on arm lymphedema volume maintenance and quality of life in breast cancer survivors who have completed intensive reduction treatment for their lymphedema.

Methods-DesignThe study will be a parallel 3-arm, multi-centre randomized fast-track trial. A total of 120 women with breast cancer related lymphedema will be recruited from 3 centres in Canada and randomized to group 1: Day-time compression garment alone or Group 2: Day-time compression garment + night-time compression bandaging or Group 3: Day-time compression garment + use of a night-time compression system garment. The duration of the primary intervention period will be 12 weeks. The follow-up period after the intervention weeks 13 to 24 will follow a longitudinal observational design. The primary outcome variables: differences from baseline to week 12 in arm volume and quality of life Lymphoedema Functioning, Disability and Health Questionnaire: Lymph-ICF. Secondary outcomes include bioimpedance analysis, sleep disturbance and self-efficacy. All measurements are standardized and will be performed prior to randomization, and at weeks 6, 12, 18 and 24.

DiscussionThe use of night-time compression as a self-management strategy for chronic breast cancer related lymphedema is seen as an innovative approach to improve long-term control over the condition. This trial aims to advance the knowledge on self-management strategies for lymphedema.

Trial registrationThis trial was registered at clinicaltrials.gov on July 9, 2014 NCT02187289

KeywordsBreast cancer Lymphedema Compression therapy Physical therapy AbbreviationsCBCompression bandaging

DLTDecongestive lymphatic therapy

MLDManual lymphatic drainage

NCSGNight-time compression system garment

Author: Margaret L. McNeely - Kristin L. Campbell - Marc Webster - Urve Kuusk - Karen Tracey - John Mackey

Source: https://link.springer.com/

Related documents